Palatin Technologies, Inc. (PTN)
10.48
0.00 (0.00%)
USD |
NASDAQ |
Aug 31, 10:20
Palatin Technologies Free Cash Flow : -14.98M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2026 | -14.98M |
| December 31, 2025 | -15.88M |
| September 30, 2025 | -15.91M |
| June 30, 2025 | -21.31M |
| March 31, 2025 | -23.70M |
| December 31, 2024 | -26.95M |
| September 30, 2024 | -32.61M |
| June 30, 2024 | -31.50M |
| March 31, 2024 | -34.68M |
| December 31, 2023 | -27.60M |
| September 30, 2023 | -26.89M |
| June 30, 2023 | -29.71M |
| March 31, 2023 | -27.80M |
| December 31, 2022 | -35.85M |
| September 30, 2022 | -32.43M |
| June 30, 2022 | -30.18M |
| March 31, 2022 | -30.96M |
| December 31, 2021 | -24.91M |
| September 30, 2021 | -32.95M |
| June 30, 2021 | -22.65M |
| March 31, 2021 | -20.19M |
| December 31, 2020 | -19.20M |
| September 30, 2020 | -9.698M |
| June 30, 2020 | 41.26M |
| March 31, 2020 | 40.39M |
| Date | Value |
|---|---|
| December 31, 2019 | 39.06M |
| September 30, 2019 | 38.49M |
| June 30, 2019 | -21.82M |
| March 31, 2019 | -4.393M |
| December 31, 2018 | -7.780M |
| September 30, 2018 | -5.282M |
| June 30, 2018 | 1.681M |
| March 31, 2018 | -21.82M |
| December 31, 2017 | 28.91M |
| September 30, 2017 | 20.77M |
| June 30, 2017 | 12.75M |
| March 31, 2017 | 12.07M |
| December 31, 2016 | -41.65M |
| September 30, 2016 | -44.56M |
| June 30, 2016 | -47.38M |
| March 31, 2016 | -43.15M |
| December 31, 2015 | -38.25M |
| September 30, 2015 | -28.50M |
| June 30, 2015 | -13.36M |
| March 31, 2015 | -8.407M |
| December 31, 2014 | -4.593M |
| September 30, 2014 | -4.437M |
| June 30, 2014 | -12.21M |
| March 31, 2014 | -12.76M |
| December 31, 2013 | -14.57M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Decoy Therapeutics, Inc. | -8.367M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
| Alnylam Pharmaceuticals, Inc. | 793.94M |
| Anika Therapeutics, Inc. | 0.562M |
| Savara, Inc. | -110.66M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.417M |
| Cash from Investing (Quarterly) | -0.0385M |
| Cash from Financing (Quarterly) | 0.1389M |
| Free Cash Flow Per Share (Quarterly) | -1.139 |
| Free Cash Flow to Equity (Quarterly) | -4.394M |
| Free Cash Flow to Firm (Quarterly) | -4.454M |
| Free Cash Flow Yield | -67.44% |